April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Evaluation on the Association of the Variants in Complement Component 5 Gene and Age Related Macular Degeneration
Author Affiliations & Notes
  • Y. Chen
    Ophthalmology, Shiley Eye Center, San Diego, California
    Ophthalmology, Moran Eye Center, Salt Lake City, Utah
  • C. Zhao
    Ophthalmology, Shiley Eye Center, San Diego, California
    Ophthalmology, Moran Eye Center, Salt Lake City, Utah
  • B. Li
    Ophthalmology, Shiley Eye Center, San Diego, California
  • X. Sun
    Ophthalmology, Shiley Eye Center, San Diego, California
    Ophthalmology, Moran Eye Center, Salt Lake City, Utah
  • Z. Yang
    Ophthalmology, Shiley Eye Center, San Diego, California
    Ophthalmology, Moran Eye Center, Salt Lake City, Utah
  • K. Zhang
    Ophthalmology, Shiley Eye Center, San Diego, California
    Ophthalmology, Moran Eye Center, Salt Lake City, Utah
  • Footnotes
    Commercial Relationships  Y. Chen, None; C. Zhao, None; B. Li, None; X. Sun, None; Z. Yang, None; K. Zhang, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 3440. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Y. Chen, C. Zhao, B. Li, X. Sun, Z. Yang, K. Zhang; Evaluation on the Association of the Variants in Complement Component 5 Gene and Age Related Macular Degeneration. Invest. Ophthalmol. Vis. Sci. 2009;50(13):3440.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Dysregulation of complement cascade has been implicated in the pathogenetic mechanisms of age related macular degeneration (AMD). Significant association between AMD and several complement associated genes including complement factor H (CFH), complement component 2 (C2), complement component 3 (C3), and complement factor B (CFB) were demonstrated. Complement component 5 (C5) is a key regulator of final pathway of complement cascade. The aim of this study is to evaluate the association of variants in C5 and AMD.

Methods: : Unrelated AMD patients (n=335), including neovascular AMD (n=171) and Geographic Atrophy (n=164), and age-matched control subjects (n=186) were analyzed for six single nucleotide polymorphisms (SNPs) in C5: rs10733650, rs2416811, rs7031128, rs3815467, rs17216529, rs10739585, rs17611. SNPs were selected with minor allele frequency (MAF) >5% in Caucasian population. Genotyping was undertaken on a multiplexed SNaPshot technology platform (ABI). Association analysis was performed using Pearson’s X2 test.

Results: : All SNPs showed similar allele frequencies in both cases and controls. No statistic significant association was observed between C5 and AMD: rs10733650 (MAF=0.42 in case and 0.41 in control, Pallele=0.68), rs2416811 (MAF= 0.44 in case and 0.45 in control, Pallele =0.77), rs7031128 (MAF=0.23 in case and 0.22 in control, Pallele =0.55), rs3815467 (MAF=0.20 in case and 0.22 in control, Pallele =0.38), rs17216529 (MAF=0.06 in case and 0.08 in control, Pallele =0.20), rs10739585 (MAF=0.24 in case and 0.26 in control, Pallele =0.36). Subgroup analysis did not show any association either when comparing neovascular AMD and Geographic Atrophy with controls separately.

Conclusions: : In our preliminary analysis of a small cohort of patients, variations in C5 do not contribute to a major risk of AMD. Genotyping more SNPs with better coverage and investigation of possible allelic and haplotype interactions may further clarify the role of C5 in AMD risk.

Keywords: age-related macular degeneration • genetics 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×